CXCR3 and central nervous system cancer: Importantly, such Th1 secretome – driven by CXCR3 ligands – was preclinically demonstrated as critical for cytotoxic lymphocyte recruitment enabling the efficacy of glioma vaccines as well as ICB in solid tumors [60, 80].